This research aims to develop a novel cancer immunotherapy by engineering bacteriophages to target and block the epidermal growth factor receptor (EGFR). We created a model cancer cell line by introducing EGFR DNA into mammalian cells. Using a phage display library containing 10 million unique bacteriophages we screened (or you might say "will screen') for phages capable of binding to and blocking EGFR. Successful identification of EGFR-blocking phages could lead to the development of a new class of targeted cancer immunotherapy that harnesses the natural targeting capabilities of bacteriophages to disrupt cancer cell growth signals mediated by EGFR overexpression.
EGFR-Targeted Phage Screening: Like Speed Dating, but for Science
Resource Type
Poster
Event
Summer Undergraduate Research Program (SURP) Symposium (University of West Florida, Pensacola, Florida, 08/2025)
Contributors
Rodney Guttmann (Faculty Mentor)
Publisher
University of West Florida Libraries; Argo Scholar Commons
Format
pdf
Copyright
Permission granted to the University of West Florida Libraries by the author to digitize and/or display this information for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires the permission of the copyright holder.
Identifiers
99381555074206600
Academic Unit
Biology; Summer Undergraduate Research Program 2025; Hal Marcus College of Science and Engineering